Viridian Therapeutics Inc - VRDN - stock price prediction, stock price target, analyst ratings from 17 analysts

Viridian Therapeutics Inc has a share price target of US$ 37, revenue growth forecast of -57.6%, and profit growth estimate of -34.1% for FY26, based on top 17 analyst calls.